Altimmune (ALT) Return on Capital Employed Growth (1y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 68,255.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 2,665.00 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 31,429.00 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 2,503.00 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -105.00 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 2,400.00 |
| 10 | Altimmune | 379.61 Mn | 379.61 Mn | - | 3,821.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,821.00 |
| Dec 31, 2025 | 3,716.00 |
| Sep 30, 2025 | 2,649.00 |
| Jun 30, 2025 | 887.00 |
| Mar 31, 2025 | -1,725.00 |
| Dec 31, 2024 | -2,314.00 |
| Sep 30, 2024 | -2,128.00 |
| Jun 30, 2024 | -1,579.00 |
| Mar 31, 2024 | -422.00 |
| Dec 31, 2023 | -1,028.00 |
| Sep 30, 2023 | -846.00 |
| Jun 30, 2023 | -36.00 |
| Mar 31, 2023 | 314.00 |
| Dec 31, 2022 | 216.00 |
| Sep 30, 2022 | -720.00 |
| Jun 30, 2022 | -2,272.00 |
| Mar 31, 2022 | -2,712.00 |
| Dec 31, 2021 | -2,210.00 |
| Sep 30, 2021 | -676.00 |
| Jun 30, 2021 | 2,889.00 |
| Mar 31, 2021 | 2,951.00 |
| Dec 31, 2020 | 1,771.00 |
| Sep 30, 2020 | 4,851.00 |
| Jun 30, 2020 | 571.00 |
| Mar 31, 2020 | 1,449.00 |
| Dec 31, 2019 | 4,508.00 |
| Sep 30, 2019 | -1,490.00 |
| Jun 30, 2019 | 4,925.00 |
| Mar 31, 2019 | 2,478.00 |
| Dec 31, 2018 | -667.00 |
| Sep 30, 2018 | -618.00 |
| Jun 30, 2018 | -7,372.00 |
| Mar 31, 2018 | -3,416.00 |
| Dec 31, 2017 | -6,459.00 |
| Sep 30, 2017 | -4,671.00 |
| Jun 30, 2017 | -1,028.00 |
| Mar 31, 2017 | -2,516.00 |
| Dec 31, 2016 | 303.00 |
| Sep 30, 2016 | 1,558.00 |
| Jun 30, 2016 | 866.00 |
| Mar 31, 2016 | -38.00 |
| Jun 30, 2015 | 6,307.00 |
| Mar 31, 2015 | 6,430.00 |
| Jun 30, 2014 | -6,170.00 |
| Mar 31, 2014 | -5,927.00 |
| Dec 31, 2013 | -4,951.00 |
| Sep 30, 2013 | -629.00 |
| Jun 30, 2013 | 120.00 |
| Mar 31, 2013 | 795.00 |
| Dec 31, 2012 | 2,640.00 |
| Sep 30, 2012 | 5,259.00 |